Work

A Phase II Study of Lenalidomide for Previously Untreated Deletion (del) 5q Acute Myeloid Leukemia (AML) Patients Age 60 or Older Who Are Not Candidates for Remission Induction Chemotherapy (Southwest Oncology Group Study S0605)

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.332.332

Authors: Mikkael A. Sekeres, Holly Gundacker, Jeffrey Lancet, Anjali Advani, Stephen Petersdorf, Jane L. Liesveld, Deborah Mulford, Tom Norwood, Cheryl L. Willman, Alan F. List, Frederick R. Appelbaum

Institutions: Cleveland Clinic, SWOG Cancer Research Network, Moffitt Cancer Center, Seattle Cancer Care Alliance, University of Rochester Medicine, University of Rochester, University of Washington, UNM Comprehensive Cancer Center, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980030532

FWCI: 1.437

Cites:

Cited by: 8

Related to: 10